MAPT and Alzheimer disease: A recent study by Franzmeier and colleagues63 demonstrated that CSF α-syn SAA positivity was associated with greater amyloid β-related increases in p-tau181, higher tau-PET burden in AD-typical regions, and faster longitudinal tau accumulation.